Unfortunately, we could not validate this effect of RNF31 on anti-tumor immunity in our cohort of patients with HCC, since we identified no correlation between tumor-infiltrating CD8+ cells and levels of RNF31 expression (Table 1). The gene discussed is CD8A; the disease is neoplasm.